Wolfville, Canada Clinical Trials

A listing of Wolfville, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiority of lecanemab compared with placebo on the change from baseline in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) at 18 months of treatment in the Core Study. This …

True North Clinical Research Kentville, Inc.
 (6.7 away) Contact site
  • 242 views
  • 05 Jul, 2021
  • +275 other locations
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease. Participants will either get semaglutide or placebo (a "dummy" medicine which does not contain any study medicine) - which treatment participants get is decided by an equal chance. The study will …

Novo Nordisk Investigational Site
 (5.7 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +138 other locations
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

This study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. This is a double-blind, randomized trial with one dose of ALZ-801 compared to placebo.

True North Clinical Research
 (5.7 away) Contact site
  • 0 views
  • 24 Jul, 2021
  • +67 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

mini-mental state examination
flortaucipir
alzheimer's disease
positron emission tomography
florbetapir
True North Clinical Research
 (5.7 away) Contact site
  • 79 views
  • 24 Jul, 2021
  • +389 other locations
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

crohn's disease
ustekinumab
Viable Clinical Research
 (6.9 away) Contact site
  • 646 views
  • 25 Jul, 2021
  • +991 other locations
A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease

The purpose of this study is to evaluate the safety, tolerability and efficacy of GV-971 in mild to moderate Alzheimer's disease.

mini-mental state examination
alzheimer's disease
True North Clinical Research/Site 1011
 (5.7 away) Contact site
  • 0 views
  • 02 Jul, 2021
  • +69 other locations
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

A phase 2 randomized, double blind, placebo controlled study evaluating the efficacy and safety of AL002 in participants with Early Alzheimer's Disease.

mini-mental state examination
alzheimer's disease
amyloidosis
True North Clinical Research - New Minas
 (5.7 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +85 other locations
ANAVEX2-73 for Treatment of Early Alzheimer's Disease

Phase 2b/3 48-week study to evaluate the effects of ANAVEX2-73 on cognition and function after 48 weeks of daily treatment. Additional outcome measures include refined measures of sleep, behavioral and psychological symptoms typically observed in AD, changes in daily functioning of participants and changes in caregiver burden, as well as …

positron emission tomography
cognitive impairment
mini-mental state examination
mental state examination
dementia
True North Clinical Research
 (6.6 away) Contact site
  • 250 views
  • 09 May, 2021
  • +53 other locations
Psoriasis Longitudinal Assessment and Registry

The purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis. The study also includes patients receiving other therapies, such as non-biologic and other biologic agents. The registry also evaluates patient and disease characteristics, including patient-reported …

ustekinumab
biological drug
ixekizumab
secukinumab
methotrexate
Michael Shaffelburg M.D.
 (6.7 away) Contact site
  • 4031 views
  • 17 Jul, 2021
  • +491 other locations